West Pharmaceutical Services WST
NYSE WST
$393.69 +4.91 (+1.26%)
As of: Oct 21, 2026 · 3:59 PM EDT

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026)

Updated

Analysis

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 West Pharmaceutical Services 27.96 Bn 25.58 Bn 329.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 900,000.00
Dec 31, 2025 2.90 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 800,000.00
Dec 31, 2019 700,000.00
Sep 30, 2019 1.20 Mn
Jun 30, 2019 100,000.00
Mar 31, 2019 300,000.00
Dec 31, 2018 1.40 Mn
Sep 30, 2018 400,000.00
Jun 30, 2018 300,000.00
Mar 31, 2018 100,000.00
API Access

West Pharmaceutical Services Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=WST&period=max&api_key=YOUR_API_KEY